Polygenic Score (PGS) ID: PGS000837

Predicted Trait
Reported Trait Insulin sensitivity index
Mapped Trait(s) insulin sensitivity measurement (EFO_0004471)
Released in PGS Catalog: Nov. 4, 2021
Download Score FTP directory
Terms and Licenses
PGS obtained from the Catalog should be cited appropriately, and used in accordance with any licensing restrictions set by the authors. See EBI Terms of Use (https://www.ebi.ac.uk/about/terms-of-use/) for additional details.

Score Details

Score Construction
PGS Name ISI
Development Method
Name Genome-wide significant variants
Parameters r2=0.5, 250kb window
Variants
Original Genome Build GRCh37
Number of Variants 219
Effect Weight Type NR
PGS Source
PGS Catalog Publication (PGP) ID PGP000211
Citation (link to publication) Aly DM et al. Nat Genet (2021)
Ancestry Distribution
Source of Variant
Associations (GWAS)
European: 100%
16,753 individuals (100%)
PGS Evaluation
European: 83.3%
South Asian: 16.7%
6 Sample Sets

Development Samples

Source of Variant Associations (GWAS)
Loading, please wait
Study Identifiers
Sample Numbers
Sample Ancestry
Cohort(s)
GWAS Catalog: GCST003659
Europe PMC: 27416945
16,753 individualsEuropeanNR
Showing 1 to 1 of 1 rows

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

Loading, please wait
PGS Performance
Metric ID (PPM)
PGS Sample Set ID
(PSS)
Performance Source
Trait
PGS Effect Sizes
(per SD change)
Classification Metrics
Other Metrics
Covariates Included in the Model
PGS Performance:
Other Relevant Information
PPM002268PSS001086|
European Ancestry|
3,194 individuals
PGP000211 |
Aly DM et al. Nat Genet (2021)
Reported Trait: Severe Autoimmune DiabetesOR: 0.92 [0.83, 1.01]PC1-10
PPM002269PSS001087|
European Ancestry|
3,930 individuals
PGP000211 |
Aly DM et al. Nat Genet (2021)
Reported Trait: Severe Insulin-Deficient DiabetesOR: 0.93 [0.86, 0.99]PC1-10
PPM002270PSS001088|
European Ancestry|
3,869 individuals
PGP000211 |
Aly DM et al. Nat Genet (2021)
Reported Trait: Severe Insulin-Resistant DiabetesOR: 0.84 [0.79, 0.91]PC1-10
PPM002271PSS001085|
European Ancestry|
4,116 individuals
PGP000211 |
Aly DM et al. Nat Genet (2021)
Reported Trait: Moderate Obesity-related DiabetesOR: 0.88 [0.82, 0.94]PC1-10
PPM002272PSS001084|
European Ancestry|
5,597 individuals
PGP000211 |
Aly DM et al. Nat Genet (2021)
Reported Trait: Moderate Age-Related DiabetesOR: 0.95 [0.9, 1.0]PC1-10
PPM020179PSS011301|
South Asian Ancestry|
1,282 individuals
PGP000525 |
Yajnik CS et al. Lancet Reg Health Southeast Asia (2023)
|Ext.
Reported Trait: HOMA2IRβ: -0.09902 (0.047574)
Showing 1 to 6 of 6 rows

Evaluated Samples

Loading, please wait
PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods
Participant Follow-up Time
Sample Numbers
Age of Study Participants
Sample Ancestry
Additional Ancestry Description
Cohort(s)
Additional Sample/Cohort Information
PSS001084Moderate Age-Related Diabetes (MARD) vs. controls
[
  • 2,853 cases
  • , 2,744 controls
]
EuropeanSwedishANDIS
PSS001085Moderate Obesity-related Diabetes (MOD) vs. controls
[
  • 1,372 cases
  • , 2,744 controls
]
EuropeanSwedishANDIS
PSS001086Severe Autoimmune Diabetes (SAID) vs. controls
[
  • 450 cases
  • , 2,744 controls
]
EuropeanSwedishANDIS
PSS001087Severe Insulin-Deficient Diabetes (SIDD) vs. controls
[
  • 1,186 cases
  • , 2,744 controls
]
EuropeanSwedishANDIS
PSS001088Severe Insulin-Resistant Diabetes (SIRD) vs. controls
[
  • 1,125 cases
  • , 2,744 controls
]
EuropeanSwedishANDIS
PSS011301
[
  • 821 cases
  • , 461 controls
]
South Asian
(Indian)
WellGen
Showing 1 to 6 of 6 rows
This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our Privacy Notice and Terms of Use.